[go: up one dir, main page]

AU2001271068A1 - Matrix metalloprotease inhibitors - Google Patents

Matrix metalloprotease inhibitors

Info

Publication number
AU2001271068A1
AU2001271068A1 AU2001271068A AU7106801A AU2001271068A1 AU 2001271068 A1 AU2001271068 A1 AU 2001271068A1 AU 2001271068 A AU2001271068 A AU 2001271068A AU 7106801 A AU7106801 A AU 7106801A AU 2001271068 A1 AU2001271068 A1 AU 2001271068A1
Authority
AU
Australia
Prior art keywords
matrix metalloprotease
metalloprotease inhibitors
inhibitors
matrix
metalloprotease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001271068A
Inventor
Yoshiki Hayashi
Teruo Nakamura
Akira Okamachi
Tatsuya Tamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2001271068A1 publication Critical patent/AU2001271068A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001271068A 2000-07-18 2001-07-17 Matrix metalloprotease inhibitors Abandoned AU2001271068A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000216790 2000-07-18
JP2000-216790 2000-07-18
JP2000398635 2000-12-27
JP2000-398635 2000-12-27
PCT/JP2001/006172 WO2002006227A1 (en) 2000-07-18 2001-07-17 Matrix metalloprotease inhibitors

Publications (1)

Publication Number Publication Date
AU2001271068A1 true AU2001271068A1 (en) 2002-01-30

Family

ID=26596201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001271068A Abandoned AU2001271068A1 (en) 2000-07-18 2001-07-17 Matrix metalloprotease inhibitors

Country Status (2)

Country Link
AU (1) AU2001271068A1 (en)
WO (1) WO2002006227A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2618821A4 (en) 2010-09-24 2014-08-13 Brigham & Womens Hospital NANOSTRUCTURED GELS CAPABLE OF CONTROLLED RELEASE OF ENCAPSULATED AGENTS
JP7169880B2 (en) * 2016-05-06 2022-11-11 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド A Two-Component Self-Assembling Gel for Controlled Delivery of Encapsulated Drugs to Cartilage
CA3113948A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601368D0 (en) * 1986-01-21 1986-02-26 Ici America Inc Hydroxamic acids
FR2609289B1 (en) * 1987-01-06 1991-03-29 Bellon Labor Sa Roger NOVEL COMPOUNDS HAVING ACTIVITY OF COLLAGENASE INHIBITORS, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
ES2069833T3 (en) * 1990-12-03 1995-05-16 Celltech Ltd PEPTIDILIC DERIVATIVES.
GB9102635D0 (en) * 1991-02-07 1991-03-27 British Bio Technology Compounds
GB9211706D0 (en) * 1992-06-03 1992-07-15 Celltech Ltd Peptidyl derivatives
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
WO1995004033A1 (en) * 1993-08-02 1995-02-09 Celltech Limited Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
JPH09503201A (en) * 1993-08-23 1997-03-31 イミュネックス・コーポレーション Inhibitor of TNF-alpha secretion
WO1996033968A1 (en) * 1995-04-25 1996-10-31 Fuji Yakuhin Kogyo Kabushiki Kaisha Highly water-soluble metalloproteinase inhibitor
AU7335496A (en) * 1995-10-23 1997-05-15 Sankyo Company Limited Hyroxamic acid derivatives
GB9601041D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Novel compounds
AU2291397A (en) * 1996-03-26 1997-10-17 Glaxo Group Limited Tumor necrosis factor alpha convertase
GB9609795D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
GB9613547D0 (en) * 1996-06-27 1996-08-28 Pharmacia Spa Matrix metalloproteinase inhibitors
ATE259640T1 (en) * 1996-12-17 2004-03-15 Warner Lambert Co USE OF MATRIX METALLOPROTEINASE INHIBITORS TO PROMOTE WOUND HEALING
JPH111430A (en) * 1997-04-15 1999-01-06 Sankyo Co Ltd Medicine containing hydroxamic acid derivative
JP2001500533A (en) * 1997-07-10 2001-01-16 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー Matrix metalloproteinase inhibitors
CA2313649A1 (en) * 1997-12-12 1999-06-24 Tadanori Morikawa Novel metalloproteinase inhibitors
CA2337859A1 (en) * 1998-07-17 2000-01-27 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel agents for treating allergic diseases
CA2337898A1 (en) * 1998-07-17 2000-01-27 Fuji Yakuhin Kogyo Kabushiki Kaisha Agents for treating allergic diseases
JP2001055327A (en) * 1999-06-11 2001-02-27 Fuji Chemical Industries Ltd New medicine containing hydroxamic acid derivative

Also Published As

Publication number Publication date
WO2002006227A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
AU2002228302A1 (en) Matrix metalloproteinase inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU3831901A (en) Matrix metalloproteinase inhibitors
GB9912961D0 (en) Metalloprotease inhibitors
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2001296961A1 (en) 17-beta-hydroxysteroid dehydrogenase-ii inhibitors
AU2001269836A1 (en) Proteases
AU2002211663A1 (en) Nf-$g(k)b inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001294557A1 (en) Thrombin inhibitors
PL350452A1 (en) Dihetero-substituted metalloprotease inhibitors
AU4433700A (en) Prolyl endopeptidase inhibitor
AU2002211662A1 (en) Nf-kappab inhibitors
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
HUP0101300A3 (en) Matrix metalloprotease inhibitors
AU2001274894A1 (en) Novel matrix metalloproteinases
AU2001241498A1 (en) Matrix metalloproteinase inhibitors and uses thereof
AU2002239753A1 (en) Proteases
AU1588901A (en) Protease inhibitors
AU2001247483A1 (en) Proteases
HUP0302904A3 (en) Matrix metalloproteinase inhibitors
AU1474801A (en) Protease inhibitors
AU2001278997A1 (en) Thrombin inhibitors
AU3888200A (en) Protease inhibitors